An Institutional Policy on the Right to Benefit from the Commercialization of Human Biological Material

, , &
Journal of Law, Medicine and Ethics 18 (1-2):162-167 (1990)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1748-720x.1990.tb01144.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,497

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Institutional Entrepreneurs as Political Actors.Richard Windischhofer & Mika Skippari - 2008 - Proceedings of the International Association for Business and Society 19:410-420.
Different types—different rights.Barbro Björkman - 2007 - Science and Engineering Ethics 13 (2):221-233.
Making the Social World: The Structure of Human Civilization.John R. Searle (ed.) - 2009 - , US: Oxford University Press.
Policy metrics under scrutiny : the legacy of new public management.Daniel Tarschys - 2010 - In Hans Joas (ed.), The benefit of broad horizons: intellectual and institutional preconditions for a global social science: festschrift for Bjorn Wittrock on the occasion of his 65th birthday. Leiden [etc.]: Brill. pp. 24--33.
Science, democracy, and public policy.Kristin Shrader-Frechette - 1992 - Critical Review: A Journal of Politics and Society 6 (2):255-264.
Alternatives of Informed Consent for Storage and Use of Human Biological Material for Research Purposes: Brazilian Regulation.Gabriela Marodin, Paulo Henrique Condeixa de França, Jennifer Braathen Salgueiro, Marcia Luz da Motta, Gysélle Saddi Tannous & Anibal Gil Lopes - 2012 - Developing World Bioethics 12 (3):127-131.
Justice and the convention on biological diversity.Doris Schroeder & Thomas Pogge - 2009 - Ethics and International Affairs 23 (3):267-280.
Cognition and biological evolution an approach from idealist philosophy resolves a fundamental paradox.Dr Axel Randrup - 2006
The scope and limits of biological explanations in archaeology.Ben Jeffares - 2003 - Dissertation, Victoria University of Wellington
“Snake-oil,” “quack medicine,” and “industrially cultured organisms:” biovalue and the commercialization of human microbiome research. [REVIEW]Melody J. Slashinski, Sheryl A. McCurdy, Laura S. Achenbaum, Simon N. Whitney & Amy L. McGuire - 2012 - BMC Medical Ethics 13 (1):28-.
Biological-mereological coincidence.Judith K. Crane - 2012 - Philosophical Studies 161 (2):309-325.
Regulation, Compensation, and the Loss of Life: What Cost-Benefit Analysis Really Requires.Ty Raterman - 2012 - Ethics, Policy and Environment 15 (1):97-118.
Artificial systems as models in biological cybernetics.Titus R. Neumann, Susanne Huber & Heinrich H. Bülthoff - 2001 - Behavioral and Brain Sciences 24 (6):1071-1072.
A Critique of the Incentives Argument for Inequalities.Max Seeger - 2011 - Kriterion - Journal of Philosophy 25 (1):40-52.

Analytics

Added to PP
2010-08-31

Downloads
21 (#743,384)

6 months
3 (#984,719)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

At Law: Who's Afraid of the Human Genome?George J. Annas - 1989 - Hastings Center Report 19 (4):19.
Of Morals, Markets, and Medicine.Gordon Bermant, Peter Brown & Gerald Dworkin - 1975 - Hastings Center Report 5 (1):14-16.

View all 6 references / Add more references